Home Page |
References | OMIM | Gene | GeneReviews | HGMD | HGNC |
GENATLAS PHENOTYPE |
last update : 13/06/2006 |
Symbol | ARMS | |||
Location | 1p36.13 or 2q36.1 and 13q14.11 | |||
Name | alveolar rhabdomyosarcoma | |||
Corresponding gene | PAX7 , PAX3 , FOXO1 | |||
Other symbol(s) | RMS2, RMSA | |||
Main clinical features |
| |||
Genetic determination
Function/system disorder
| neoplasia | Type
| malignancy
| |
Gene product |
Name | fusion transcripts PAX3-FKHR and PAX7-FKHR |
Mechanism(s) |
Gene mutation | Chromosome rearrangement | Effect | Comments |
|  
| translocation
| other
| acquired t(2;13)(q35;q14), most common with frequent genomic amplification
|  
| translocation
| other
| acquired t(1;13)(p36;q14)less frequent and rarely amplified
|  
| other
|  
| double minutes (dm)with amplification of MDM, SAS, CDK4 genes
|  
| other
|  
| MYCN amplification
| |
Remark(s) | 20 percent without detectable characteristic fusion transcripts |
Genotype/Phenotype correlations | expression of PAX3-FKHR and PAX7-FKHR identifies a very high-risk subgroup and a favorable outcome subgroup, respectively, among patients presenting with metastatic ARMS. A non-coding RNA (NCRMS) may differentiate two subtypes of rhabdomyosarcoma |